Fedratinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 March 2025

  • curprev 20:3020:30, 9 March 2025 Omid Afkhami-Ardakani talk contribs 6,628 bytes +6,628 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Fedratinib |aOrAn=a |drugClass=Janus Kinase 2 (JAK2) Inhibitor |indicationType=treatment |indication=adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). |hasBlackBoxWarning=Yes |adverseReactions=Diarrhea, Nausea, Vomiting, Fatigue, Anemia, Thrombocytopenia, Elevated liver enzymes (ALT/AST), and Elevated..."
Retrieved from "https://www.wikidoc.org/index.php/Fedratinib"